| Literature DB >> 23862150 |
Yasuhiko Abe1, Yohei Okazaki, Kyou Hiasa, Keisuke Yasuda, Keisuke Nogami, Wataru Mizumachi, Isao Hirata.
Abstract
The purpose of this study was to establish an acid-etching procedure for altering the Ca/P ratio of the nanostructured surface of class="Chemical">hydroxyapatite (HAP) by using surface chemical and morphological analyses (XPS, XRD, SEM, surface roughness, and wettability) and to evaluate the in vitro response of osteoblast-like cells (Entities:
Mesh:
Substances:
Year: 2013 PMID: 23862150 PMCID: PMC3687726 DOI: 10.1155/2013/626452
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Modified schematic diagram representing the phenomena that occur on the surface of hydroxyapatite (Ca10(PO4)6(OH)2: HAP) after implantation, illustrated by Bertazzo et al. [13]. Phase I: beginning of the implant procedure, where the solubilization of the HAP surface starts. Phase II: continuation of the solubilization of the HAP surface (tricalcium phosphate, Ca3(PO4)2: TCP). Phase III: achievement of equilibrium between physiological solutions and the modified surface of HAP (dicalcium phosphate dehydrate (brushite), CaHPO4 ·2H2O: DCPD).
XPS-determined binding energies (eV) of Ca 2p, P 2p, and Δ(Ca 2p, P 2p); atomic concentrations (at. %); and Ca/P ratios for hydroxyapatite (HAP) and HAP treated with 10%, 20%, 30%, 40%, 50%, or 60% phosphoric acid (HAP—10% PA, HAP—20% PA, HAP—30% PA, HAP—40% PA, HAP—50% PA, and HAP—60% PA).
| Sample | Binding energy (eV) | At. % | Ca/P | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Ca 2p | P 2p | Δ(Ca 2p, P 2p) | C 1s | O 1s | Ca 2p | P 2p | |||
| HAP | Mean | 346.51 | 132.45 | 214.06a | 26.81 | 47.74 | 15.84 | 9.61 | 1.65 |
| SD | 0.03 | 0.05 | 0.05 | 2.02 | 1.35 | 0.50 | 0.31 | 0.02 | |
| HAP—10% PA | Mean | 346.87 | 132.80 | 214.07a | 11.04 | 58.00 | 18.80 | 12.17 | 1.54c |
| SD | 0.05 | 0.05 | 0.05 | 1.06 | 0.58 | 0.34 | 0.18 | 0.01 | |
| HAP—20% PA | Mean | 346.77 | 132.72 | 214.05a | 15.70 | 54.75 | 17.77 | 11.78 | 1.51b |
| SD | 0.09 | 0.09 | 0.05 | 6.12 | 3.76 | 1.52 | 0.84 | 0.02 | |
| HAP—30% PA | Mean | 346.61 | 132.54 | 214.07a | 25.80 | 49.32 | 14.92 | 9.96 | 1.50b |
| SD | 0.06 | 0.07 | 0.05 | 1.09 | 1.36 | 0.58 | 0.54 | 0.03 | |
| HAP—40% PA | Mean | 346.85 | 132.79 | 214.06a | 9.94 | 57.77 | 19.66 | 12.63 | 1.56c,d |
| SD | 0.05 | 0.07 | 0.05 | 0.83 | 0.61 | 0.18 | 0.11 | 0.02 | |
| HAP—50% PA | Mean | 346.91 | 132.88 | 214.03a | 11.10 | 57.48 | 19.19 | 12.24 | 1.57c,d |
| SD | 0.07 | 0.08 | 0.05 | 1.80 | 1.10 | 0.56 | 0.25 | 0.04 | |
| HAP—60% PA | Mean | 346.73 | 132.68 | 214.05a | 10.93 | 57.78 | 19.18 | 12.11 | 1.58d |
| SD | 0.05 | 0.04 | 0.05 | 0.32 | 0.26 | 0.12 | 0.12 | 0.02 | |
The presence of the same superscript letter for the values indicates that there were no significant differences among the samples (P > 0.05).
Figure 2X-ray diffraction (XRD) spectra of HAP and HAP—30% PA thin films referenced to the ICDD standard for HAP (no. 01-072-1243). There was no difference between the XRD spectra of HAP and HAP—30% PA, and the chemical composition of their thin films was assumed to be the same.
XPS-determined binding energies (eV) of Ca 2p, P 2p, and Δ(Ca 2p, P 2p), and Ca/P ratios for hydroxyapatite (HAP), HAP treated with 30% phosphoric acid (HAP—30% PA), and HAP—30% PA in storage for 12 hours (HAP—30% PA—12 h) at each incidence angle of the X-ray (90, 75, 60, 45, 30, or 15 degrees).
| Sample | Angle of incidence (degrees) | Binding energy (eV) | Ca/P | ||
|---|---|---|---|---|---|
| Ca 2p | P 2p | Δ(Ca 2p, P 2p) | |||
| HAP | 90 | 346.60 | 132.55 | 214.05 | 1.65 |
| 75 | 346.70 | 132.60 | 214.10 | 1.59 | |
| 60 | 346.60 | 132.50 | 214.10 | 1.63 | |
| 45 | 346.65 | 132.55 | 214.10 | 1.66 | |
| 30 | 346.60 | 132.50 | 214.10 | 1.69 | |
| 15 | 346.60 | 132.55 | 214.05 | 1.68 | |
| Mean | 346.63 | 132.54 | 214.08a | 1.65b | |
| SD | 0.04 | 0.04 | 0.03 | 0.04 | |
|
| |||||
| HAP—30% PA | 90 | 346.80 | 132.75 | 214.05 | 1.45 |
| 75 | 346.80 | 132.75 | 214.05 | 1.44 | |
| 60 | 346.85 | 132.75 | 214.10 | 1.45 | |
| 45 | 346.85 | 132.80 | 214.05 | 1.44 | |
| 30 | 346.90 | 132.95 | 213.95 | 1.46 | |
| 15 | 346.90 | 132.65 | 214.25 | 1.45 | |
| Mean | 346.85 | 132.78 | 214.08a | 1.45b | |
| SD | 0.04 | 0.10 | 0.10 | 0.01 | |
|
| |||||
| HAP—30% PA—12 h | 90 | 347.30 | 133.40 | 213.90 | 1.11 |
| 75 | 347.25 | 133.40 | 213.85 | 1.10 | |
| 60 | 347.30 | 133.45 | 213.85 | 1.10 | |
| 45 | 347.30 | 133.40 | 213.90 | 1.09 | |
| 30 | 347.30 | 133.35 | 213.95 | 1.11 | |
| 15 | 347.30 | 133.30 | 214.00 | 1.06 | |
| Mean | 347.29 | 133.38 | 213.91 | 1.09b | |
| SD | 0.02 | 0.05 | 0.06 | 0.02 | |
a P > 0.05 indicates no significant difference between the samples.
b P < 0.01 indicates significant differences among the samples.
Figure 3SEM images of (a) HAP, (b) HAP—30% PA, and (c) HAP—30% PA—12 h.
Surface roughness and wettability for HAP, HAP—30% PA, and HAP—30% PA—12 h.
| Sample | Surface roughness | Wettability | |
|---|---|---|---|
| Ra ( | Contact angle (degrees) | ||
| HAP | Mean | 0.25 | 102.10c |
| SD | 0.06 | 2.98 | |
| HAP—30% PA | Mean | 0.91a | 55.13c |
| SD | 0.05 | 0.35 | |
| HAP—30% PA—12 h | Mean | 0.96a,b | 13.67c |
| SD | 0.04 | 3.54 |
Surface roughness: a P < 0.01 indicates significant difference from HAP. b P < 0.05 indicates significant difference from HAP—30% PA.
Wettability: c P < 0.01 indicates significant differences among the samples.
Figure 4Initial cell adhesion of MC3T3-E1 osteoblast-like cells to HAP, HAP—30% PA, and HAP—30% PA—12 h at 0.5 and 24 hours. At 0.5 hours, the number of cells adherent to HAP—30% PA—12 h was significantly greater than that for HAP (P < 0.05). At 24 hours, the number of cells adherent to HAP—30% PA—12 h was significantly greater than those for both HAP (P < 0.01) and HAP—30% PA (P < 0.05).
Figure 5Cell proliferation of MC3T3-E1 osteoblast-like cells on HAP, HAP—30% PA, and HAP—30% PA—12 h at 1, 4, and 7 days. At 4 and 7 days, cell proliferation on HAP—30% PA and HAP—30% PA—12 h was significantly higher than that on HAP (P < 0.01); the difference in the cell proliferation on HAP—30% PA and HAP—30% PA—12 h was not statistically different (P > 0.05).
Figure 6ALP activities of MC3T3-E1 osteoblast-like cells on HAP, HAP—30% PA, and HAP—30% PA—12 h at 7, 14, and 21 days after obtaining a confluent cell monolayer. At 14 days, the ALP activities of the cells on HAP—30% PA and HAP—30% PA—12 h were significantly higher than that on HAP (P < 0.01). The ALP activity at 14 days for HAP—30% PA—12 h was higher than that for HAP—30% PA, but the ALP activity at 21 days was lower than that for HAP—30% PA. Although the ALP activities for HAP and HAP—30% PA gradually increased from 7 to 21 days, the ALP activity for HAP—30% PA—12 h reached its peak at 14 days.
Figure 7Relative mRNA levels for ALP in MC3T3-E1 osteoblast-like cells on HAP, HAP—30% PA, and HAP—30% PA—12 h at 14, 21, and 28 days after obtaining a confluent cell monolayer. At 14 days, there was no mRNA expression on HAP, but the expression on HAP—30% PA—12 h and HAP—30% PA was estimated in sequence. At 21 days, the expression of ALP on HAP was estimated, and the expression on HAP, HAP—30% PA, and HAP—30% PA—12 h was increased at 28 days. There were no statistically significant differences among expressions at any time (P > 0.05).